Futibatinib
Otsuka
['futibatinib']
phase 2 study of futibatinib in pts with fgfr aberrations: activity in patients with gc/gej cancer harboring fgfr2 amplification at #wcgic23 only modest activity in heavily pretreated pts amplifications also challenging in btc 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision oncology